This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
1cP-LSD: Difference between revisions
>Mind at Large Hydrolysis time |
>Mind at Large History and culture |
||
| Line 5: | Line 5: | ||
The origins of 1cP-LSD are not well-documented. Following 1P-LSD's prohibition in Germany, 1cP-LSD appeared on the online [[research chemical]] market in 2019.{{citation needed}} Like other LSD analogs, it was marketed as a legal alternative to LSD and 1P-LSD. | The origins of 1cP-LSD are not well-documented. Following 1P-LSD's prohibition in Germany, 1cP-LSD appeared on the online [[research chemical]] market in 2019.{{citation needed}} Like other LSD analogs, it was marketed as a legal alternative to LSD and 1P-LSD. | ||
[[Subjective effects]] include [[geometry|open and closed eye visuals]], [[time distortion]], [[conceptual thinking]], [[introspection|enhanced introspection]], [[euphoria]], and [[ego loss]]. A study found that incubation of 1cP‐LSD with human serum led to the formation of LSD, indicating that it may act as a [[prodrug]] for LSD.<ref name="Brandt2020"></ref> Anecdotal reports appear to be consistent with this theory, with most users reporting near-identical effects as LSD | [[Subjective effects]] include [[geometry|open and closed eye visuals]], [[time distortion]], [[conceptual thinking]], [[introspection|enhanced introspection]], [[euphoria]], and [[ego loss]]. A study found that incubation of 1cP‐LSD with human serum led to the formation of LSD, indicating that it may act as a [[prodrug]] for LSD.<ref name="Brandt2020"></ref> Anecdotal reports appear to be consistent with this theory, with most users reporting near-identical effects as LSD. | ||
Limited data exist on the pharmacology, metabolism, and toxicity of 1cP-LSD. While it is presumed to have a [[LSD#Toxicity and harm potential|similar risk profile as LSD]] and its analogs, which are generally thought to be safe in controlled settings, more research is needed. It is highly advised to use [[harm reduction practices]] if using this substance. | Limited data exist on the pharmacology, metabolism, and toxicity of 1cP-LSD. While it is presumed to have a [[LSD#Toxicity and harm potential|similar risk profile as LSD]] and its analogs, which are generally thought to be safe in controlled settings, more research is needed. It is highly advised to use [[harm reduction practices]] if using this substance. | ||
| Line 11: | Line 11: | ||
==History and culture== | ==History and culture== | ||
{{historyStub}} | {{historyStub}} | ||
1cP-LSD was first discovered and synthesized in the Netherlands in 2019, and first appeared on the online research chemical market in July that same year.<ref>{{cite web|title=1cP-LSD|publisher=Google Trends|access-date=July 14, 2020|url=https://trends.google.com/trends/explore?date=all&q=1cp-lsd}}</ref> It was released shortly after the prohibition of 1P-LSD in Germany. It is part of a larger series of designer LSD analogs that have appeared on the research chemical market since the mid-2010s. These include [[AL-LAD]], [[ETH-LAD]], and [[ALD-52]]. | 1cP-LSD was first discovered and synthesized in the Netherlands in 2019, and first appeared on the online research chemical market in July that same year.<ref>{{cite web|title=1cP-LSD|publisher=Google Trends|access-date=July 14, 2020|url=https://trends.google.com/trends/explore?date=all&q=1cp-lsd}}</ref> It was released shortly after the prohibition of 1P-LSD in Germany. It is part of a larger series of designer LSD analogs that have appeared on the research chemical market since the mid-2010s. These include [[AL-LAD]], [[ETH-LAD]], and [[ALD-52]]. In July 2021, Germany banned 1cP-LSD, and immediately thereafter 1V-LSD appeared on the market as its replacement. | ||
<br /> | <br /> | ||
| Line 197: | Line 197: | ||
*[[LSD]] | *[[LSD]] | ||
*[[1P-LSD]] | *[[1P-LSD]] | ||
<!-- | |||
==External links== | ==External links== | ||
(List along order below) | |||
*[https://en.wikipedia.org/wiki/ | * [https://en.wikipedia.org/wiki/SUBSTANCE SUBSTANCE (Wikipedia)] | ||
*[ | * SUBSTANCE (Erowid Vault) | ||
* SUBSTANCE ([''PiHKAL'' or ''TiHKAL''] / Isomer Design) | |||
==Literature== | ==Literature== | ||
| Line 213: | Line 214: | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category: | [[Category:Proofread]] | ||
[[Category: | [[Category:Approval]] | ||